

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 7.77066027 |
| 2 | ribosomal small subunit assembly (GO:0000028) | 7.13709531 |
| 3 | viral transcription (GO:0019083) | 6.50211615 |
| 4 | translational termination (GO:0006415) | 6.24603487 |
| 5 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.72119204 |
| 6 | ribosomal small subunit biogenesis (GO:0042274) | 5.68435406 |
| 7 | protein targeting to ER (GO:0045047) | 5.59483330 |
| 8 | cotranslational protein targeting to membrane (GO:0006613) | 5.56394158 |
| 9 | translational elongation (GO:0006414) | 5.51060001 |
| 10 | protein localization to endoplasmic reticulum (GO:0070972) | 5.33970318 |
| 11 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 5.30929111 |
| 12 | viral life cycle (GO:0019058) | 4.90024751 |
| 13 | maturation of SSU-rRNA (GO:0030490) | 4.84424178 |
| 14 | purine deoxyribonucleotide catabolic process (GO:0009155) | 4.82729387 |
| 15 | base-excision repair, AP site formation (GO:0006285) | 4.78778773 |
| 16 | cellular protein complex disassembly (GO:0043624) | 4.74177200 |
| 17 | GTP biosynthetic process (GO:0006183) | 4.73402665 |
| 18 | deoxyribonucleotide catabolic process (GO:0009264) | 4.73117680 |
| 19 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.67847748 |
| 20 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.67649761 |
| 21 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 4.62506368 |
| 22 | translational initiation (GO:0006413) | 4.61655456 |
| 23 | deoxyribose phosphate biosynthetic process (GO:0046385) | 4.59381601 |
| 24 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 4.59381601 |
| 25 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 4.46720806 |
| 26 | pyrimidine nucleotide catabolic process (GO:0006244) | 4.36181994 |
| 27 | deoxyribose phosphate catabolic process (GO:0046386) | 4.30034444 |
| 28 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.27623473 |
| 29 | UTP biosynthetic process (GO:0006228) | 4.24818636 |
| 30 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.11858969 |
| 31 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.11681307 |
| 32 | NADH dehydrogenase complex assembly (GO:0010257) | 4.11681307 |
| 33 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.11681307 |
| 34 | chaperone-mediated protein transport (GO:0072321) | 4.11258608 |
| 35 | protein complex disassembly (GO:0043241) | 4.10523335 |
| 36 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 4.10132845 |
| 37 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 4.07285615 |
| 38 | UTP metabolic process (GO:0046051) | 3.94629813 |
| 39 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.92217408 |
| 40 | translation (GO:0006412) | 3.89579977 |
| 41 | macromolecular complex disassembly (GO:0032984) | 3.88182117 |
| 42 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.86803260 |
| 43 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.86351916 |
| 44 | negative regulation of B cell apoptotic process (GO:0002903) | 3.84862167 |
| 45 | ribosomal large subunit biogenesis (GO:0042273) | 3.78268056 |
| 46 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.77820321 |
| 47 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.77820321 |
| 48 | protein targeting to membrane (GO:0006612) | 3.75361246 |
| 49 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.73867168 |
| 50 | mitochondrial calcium ion transport (GO:0006851) | 3.73630451 |
| 51 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.71418766 |
| 52 | deoxyribose phosphate metabolic process (GO:0019692) | 3.71195396 |
| 53 | DNA strand elongation (GO:0022616) | 3.70872345 |
| 54 | purine deoxyribonucleotide metabolic process (GO:0009151) | 3.67579357 |
| 55 | mature B cell differentiation involved in immune response (GO:0002313) | 3.65542222 |
| 56 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.61750264 |
| 57 | positive regulation of prostaglandin secretion (GO:0032308) | 3.60712562 |
| 58 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.53800067 |
| 59 | CTP metabolic process (GO:0046036) | 3.52645619 |
| 60 | CTP biosynthetic process (GO:0006241) | 3.52645619 |
| 61 | oxidative phosphorylation (GO:0006119) | 3.47761377 |
| 62 | ubiquinone biosynthetic process (GO:0006744) | 3.45506826 |
| 63 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.39833308 |
| 64 | respiratory chain complex IV assembly (GO:0008535) | 3.39145714 |
| 65 | pseudouridine synthesis (GO:0001522) | 3.38513330 |
| 66 | formation of translation preinitiation complex (GO:0001731) | 3.29916363 |
| 67 | GDP-mannose metabolic process (GO:0019673) | 3.29373603 |
| 68 | telomere maintenance via recombination (GO:0000722) | 3.29230873 |
| 69 | response to interferon-beta (GO:0035456) | 3.29027204 |
| 70 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.28537148 |
| 71 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 3.24265878 |
| 72 | deoxyribonucleotide metabolic process (GO:0009262) | 3.23578348 |
| 73 | post-embryonic morphogenesis (GO:0009886) | 3.23454263 |
| 74 | mRNA catabolic process (GO:0006402) | 3.23091529 |
| 75 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.20690726 |
| 76 | purine nucleotide salvage (GO:0032261) | 3.20143967 |
| 77 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.17301974 |
| 78 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.17259261 |
| 79 | proteasome assembly (GO:0043248) | 3.16883319 |
| 80 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.16060417 |
| 81 | DNA replication initiation (GO:0006270) | 3.15428580 |
| 82 | iron-sulfur cluster assembly (GO:0016226) | 3.13897106 |
| 83 | metallo-sulfur cluster assembly (GO:0031163) | 3.13897106 |
| 84 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.13065293 |
| 85 | protein targeting to mitochondrion (GO:0006626) | 3.12279516 |
| 86 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.12197146 |
| 87 | Peyers patch development (GO:0048541) | 3.12197146 |
| 88 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.10786636 |
| 89 | establishment of protein localization to mitochondrion (GO:0072655) | 3.09560982 |
| 90 | pyrimidine nucleotide biosynthetic process (GO:0006221) | 3.08262682 |
| 91 | RNA catabolic process (GO:0006401) | 3.07865774 |
| 92 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 3.07313733 |
| 93 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.06909181 |
| 94 | cellular component biogenesis (GO:0044085) | 3.05462150 |
| 95 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.05350581 |
| 96 | grooming behavior (GO:0007625) | 3.03264209 |
| 97 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.98882016 |
| 98 | pentose-phosphate shunt (GO:0006098) | 2.97942310 |
| 99 | cytochrome complex assembly (GO:0017004) | 2.97856374 |
| 100 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.97361655 |
| 101 | ATP synthesis coupled proton transport (GO:0015986) | 2.97361655 |
| 102 | ubiquinone metabolic process (GO:0006743) | 2.96378571 |
| 103 | mannosylation (GO:0097502) | 2.94178462 |
| 104 | heme biosynthetic process (GO:0006783) | 2.92718231 |
| 105 | rRNA processing (GO:0006364) | 2.92365084 |
| 106 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.92228717 |
| 107 | pyrimidine nucleotide metabolic process (GO:0006220) | 2.90662356 |
| 108 | platelet dense granule organization (GO:0060155) | 2.89484685 |
| 109 | autophagic vacuole fusion (GO:0000046) | 2.89226381 |
| 110 | pyrimidine nucleoside biosynthetic process (GO:0046134) | 2.88489725 |
| 111 | telomere maintenance via telomere lengthening (GO:0010833) | 2.87756761 |
| 112 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.86487697 |
| 113 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.86487697 |
| 114 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.86460386 |
| 115 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.86090223 |
| 116 | negative regulation of JAK-STAT cascade (GO:0046426) | 2.83466037 |
| 117 | regulation of mitochondrial translation (GO:0070129) | 2.82046844 |
| 118 | mitotic recombination (GO:0006312) | 2.81451689 |
| 119 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.81277199 |
| 120 | regulation of prostaglandin secretion (GO:0032306) | 2.80886357 |
| 121 | negative regulation of telomere maintenance (GO:0032205) | 2.80648651 |
| 122 | protein localization to mitochondrion (GO:0070585) | 2.79901824 |
| 123 | rRNA metabolic process (GO:0016072) | 2.77668848 |
| 124 | immunoglobulin mediated immune response (GO:0016064) | 2.74784661 |
| 125 | negative regulation of RNA splicing (GO:0033119) | 2.73737854 |
| 126 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.73539542 |
| 127 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.71623893 |
| 128 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 2.71553115 |
| 129 | ncRNA 3-end processing (GO:0043628) | 2.71223704 |
| 130 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.70874597 |
| 131 | ribosome biogenesis (GO:0042254) | 2.70493481 |
| 132 | sequestering of actin monomers (GO:0042989) | 2.70157833 |
| 133 | regulation of protein heterodimerization activity (GO:0043497) | 2.69875158 |
| 134 | prostaglandin biosynthetic process (GO:0001516) | 2.68958238 |
| 135 | prostanoid biosynthetic process (GO:0046457) | 2.68958238 |
| 136 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.68073485 |
| 137 | ATP biosynthetic process (GO:0006754) | 2.68007018 |
| 138 | quinone biosynthetic process (GO:1901663) | 2.67319695 |
| 139 | pyrimidine-containing compound biosynthetic process (GO:0072528) | 2.67187751 |
| 140 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.66869109 |
| 141 | negative regulation of mRNA processing (GO:0050686) | 2.66724462 |
| 142 | pentose metabolic process (GO:0019321) | 2.66256953 |
| 143 | galactose catabolic process (GO:0019388) | 2.65313830 |
| 144 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.64942173 |
| 145 | nucleotide salvage (GO:0043173) | 2.64175460 |
| 146 | purine-containing compound salvage (GO:0043101) | 2.63993575 |
| 147 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.63637950 |
| 148 | signal peptide processing (GO:0006465) | 2.63573805 |
| 149 | actin nucleation (GO:0045010) | 2.63428398 |
| 150 | establishment of protein localization to membrane (GO:0090150) | 2.62029556 |
| 151 | respiratory electron transport chain (GO:0022904) | 2.60026794 |
| 152 | nucleoside salvage (GO:0043174) | 2.59135377 |
| 153 | cellular response to interferon-beta (GO:0035458) | 2.58844995 |
| 154 | protein targeting (GO:0006605) | 2.58656202 |
| 155 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.57180150 |
| 156 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.56989663 |
| 157 | electron transport chain (GO:0022900) | 2.54567940 |
| 158 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.53380146 |
| 159 | termination of RNA polymerase III transcription (GO:0006386) | 2.53380146 |
| 160 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.52469419 |
| 161 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.52469419 |
| 162 | protein complex biogenesis (GO:0070271) | 2.51715829 |
| 163 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.51647821 |
| 164 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.51647821 |
| 165 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.51647821 |
| 166 | B cell mediated immunity (GO:0019724) | 2.51241182 |
| 167 | NADPH regeneration (GO:0006740) | 2.49983884 |
| 168 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.49966146 |
| 169 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.49919225 |
| 170 | positive regulation of B cell differentiation (GO:0045579) | 2.49665163 |
| 171 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.48611592 |
| 172 | spliceosomal snRNP assembly (GO:0000387) | 2.47097882 |
| 173 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.46814403 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.34008496 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.19940530 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.01386651 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.62922686 |
| 5 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.05204195 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.83473434 |
| 7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.78955532 |
| 8 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.70150737 |
| 9 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.69805109 |
| 10 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.54691806 |
| 11 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.54240535 |
| 12 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.49270142 |
| 13 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.47667733 |
| 14 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.46585677 |
| 15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.44976205 |
| 16 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.44387619 |
| 17 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.31728004 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.26328231 |
| 19 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.19469467 |
| 20 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.18395630 |
| 21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.09080744 |
| 22 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.06009927 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.05951797 |
| 24 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.04135956 |
| 25 | MYC_22102868_ChIP-Seq_BL_Human | 2.03173344 |
| 26 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.02249742 |
| 27 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.01679403 |
| 28 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.91279062 |
| 29 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.90095142 |
| 30 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.86777446 |
| 31 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.85575596 |
| 32 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.83147518 |
| 33 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.81626983 |
| 34 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78927196 |
| 35 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.78358538 |
| 36 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.77447600 |
| 37 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.77320578 |
| 38 | P68_20966046_ChIP-Seq_HELA_Human | 1.76168852 |
| 39 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.75625084 |
| 40 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.73837770 |
| 41 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.72795186 |
| 42 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.71953201 |
| 43 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.71092481 |
| 44 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.69934871 |
| 45 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.68881742 |
| 46 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.68404585 |
| 47 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.65536391 |
| 48 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.64412469 |
| 49 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.60886102 |
| 50 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.60272144 |
| 51 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.59632663 |
| 52 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.57039783 |
| 53 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.53994140 |
| 54 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.52727663 |
| 55 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.51019144 |
| 56 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.50852471 |
| 57 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.50239329 |
| 58 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48756968 |
| 59 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.44975547 |
| 60 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.44483435 |
| 61 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.43249219 |
| 62 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.43105736 |
| 63 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.42816140 |
| 64 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.42736036 |
| 65 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.42148376 |
| 66 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.41030251 |
| 67 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.40031845 |
| 68 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.39679493 |
| 69 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.39595232 |
| 70 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.38645474 |
| 71 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.38243132 |
| 72 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.38055644 |
| 73 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.35092933 |
| 74 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.34578837 |
| 75 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.33353080 |
| 76 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.32454071 |
| 77 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.32302270 |
| 78 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.32282649 |
| 79 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.31158623 |
| 80 | MAF_26560356_Chip-Seq_TH1_Human | 1.30126099 |
| 81 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.29561963 |
| 82 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.28844749 |
| 83 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24668758 |
| 84 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.23356562 |
| 85 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.23156597 |
| 86 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23049210 |
| 87 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.21437706 |
| 88 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.20149372 |
| 89 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.19911797 |
| 90 | UTX_26944678_Chip-Seq_JUKART_Human | 1.18152782 |
| 91 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.17438696 |
| 92 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 1.17289389 |
| 93 | MAF_26560356_Chip-Seq_TH2_Human | 1.16493867 |
| 94 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.14688102 |
| 95 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.13954613 |
| 96 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.13814053 |
| 97 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.13089121 |
| 98 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.12145719 |
| 99 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11925219 |
| 100 | GATA1_22025678_ChIP-Seq_K562_Human | 1.11599167 |
| 101 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10787117 |
| 102 | P300_27268052_Chip-Seq_Bcells_Human | 1.10144446 |
| 103 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.10134005 |
| 104 | SA1_27219007_Chip-Seq_Bcells_Human | 1.08941920 |
| 105 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.07306359 |
| 106 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.06863936 |
| 107 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.06281892 |
| 108 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.06241110 |
| 109 | MYB_26560356_Chip-Seq_TH2_Human | 1.05510358 |
| 110 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05347817 |
| 111 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.05198665 |
| 112 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.05031904 |
| 113 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.04978903 |
| 114 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03560438 |
| 115 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.03151493 |
| 116 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.03077111 |
| 117 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.02087820 |
| 118 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.02005514 |
| 119 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.01445506 |
| 120 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.01017454 |
| 121 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.00641898 |
| 122 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.00159964 |
| 123 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00050855 |
| 124 | MYB_26560356_Chip-Seq_TH1_Human | 0.99687689 |
| 125 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.99044741 |
| 126 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.98857682 |
| 127 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.98097235 |
| 128 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.98054847 |
| 129 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.97980601 |
| 130 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.97950915 |
| 131 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.97828599 |
| 132 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.97393518 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.39711006 |
| 2 | MP0009379_abnormal_foot_pigmentation | 3.21867419 |
| 3 | MP0009278_abnormal_bone_marrow | 3.13361274 |
| 4 | MP0003693_abnormal_embryo_hatching | 3.04043566 |
| 5 | MP0009785_altered_susceptibility_to | 2.95978708 |
| 6 | MP0005645_abnormal_hypothalamus_physiol | 2.93251742 |
| 7 | MP0002396_abnormal_hematopoietic_system | 2.87730397 |
| 8 | MP0005671_abnormal_response_to | 2.82464406 |
| 9 | MP0002653_abnormal_ependyma_morphology | 2.78827281 |
| 10 | MP0000685_abnormal_immune_system | 2.78459033 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.48901095 |
| 12 | MP0005025_abnormal_response_to | 2.37702629 |
| 13 | MP0003763_abnormal_thymus_physiology | 2.32170126 |
| 14 | MP0009333_abnormal_splenocyte_physiolog | 2.31042793 |
| 15 | MP0003436_decreased_susceptibility_to | 2.30899910 |
| 16 | MP0000490_abnormal_crypts_of | 2.19859577 |
| 17 | MP0002234_abnormal_pharynx_morphology | 2.15698601 |
| 18 | MP0001853_heart_inflammation | 2.11866294 |
| 19 | MP0002398_abnormal_bone_marrow | 2.11834782 |
| 20 | MP0005000_abnormal_immune_tolerance | 2.10431794 |
| 21 | MP0001905_abnormal_dopamine_level | 2.03925863 |
| 22 | MP0006036_abnormal_mitochondrial_physio | 2.03188225 |
| 23 | MP0001800_abnormal_humoral_immune | 2.02315418 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 2.02203691 |
| 25 | MP0002822_catalepsy | 2.01257282 |
| 26 | MP0004957_abnormal_blastocyst_morpholog | 2.00850836 |
| 27 | MP0005174_abnormal_tail_pigmentation | 2.00026338 |
| 28 | MP0003724_increased_susceptibility_to | 1.99561374 |
| 29 | MP0002723_abnormal_immune_serum | 1.99169201 |
| 30 | MP0002420_abnormal_adaptive_immunity | 1.99021835 |
| 31 | MP0008789_abnormal_olfactory_epithelium | 1.95785532 |
| 32 | MP0001819_abnormal_immune_cell | 1.95433956 |
| 33 | MP0003186_abnormal_redox_activity | 1.92310663 |
| 34 | MP0000689_abnormal_spleen_morphology | 1.91514580 |
| 35 | MP0002452_abnormal_antigen_presenting | 1.89383022 |
| 36 | MP0005075_abnormal_melanosome_morpholog | 1.89071079 |
| 37 | MP0001873_stomach_inflammation | 1.87256467 |
| 38 | MP0002722_abnormal_immune_system | 1.83375679 |
| 39 | MP0000716_abnormal_immune_system | 1.83242384 |
| 40 | MP0005394_taste/olfaction_phenotype | 1.83101433 |
| 41 | MP0005499_abnormal_olfactory_system | 1.83101433 |
| 42 | MP0001545_abnormal_hematopoietic_system | 1.81465608 |
| 43 | MP0005397_hematopoietic_system_phenotyp | 1.81465608 |
| 44 | MP0006292_abnormal_olfactory_placode | 1.78898780 |
| 45 | MP0002429_abnormal_blood_cell | 1.77596918 |
| 46 | MP0002736_abnormal_nociception_after | 1.76975723 |
| 47 | MP0001968_abnormal_touch/_nociception | 1.76058549 |
| 48 | MP0005464_abnormal_platelet_physiology | 1.72504332 |
| 49 | MP0002163_abnormal_gland_morphology | 1.69074689 |
| 50 | MP0002419_abnormal_innate_immunity | 1.67801077 |
| 51 | MP0003646_muscle_fatigue | 1.63886064 |
| 52 | MP0010155_abnormal_intestine_physiology | 1.63437621 |
| 53 | MP0002166_altered_tumor_susceptibility | 1.63094003 |
| 54 | MP0002405_respiratory_system_inflammati | 1.61069071 |
| 55 | MP0003656_abnormal_erythrocyte_physiolo | 1.59318811 |
| 56 | MP0006276_abnormal_autonomic_nervous | 1.57523814 |
| 57 | MP0005646_abnormal_pituitary_gland | 1.57363852 |
| 58 | MP0003866_abnormal_defecation | 1.52127091 |
| 59 | MP0001790_abnormal_immune_system | 1.51216581 |
| 60 | MP0005387_immune_system_phenotype | 1.51216581 |
| 61 | MP0008469_abnormal_protein_level | 1.50802464 |
| 62 | MP0003077_abnormal_cell_cycle | 1.50628105 |
| 63 | MP0000858_altered_metastatic_potential | 1.49321936 |
| 64 | MP0004808_abnormal_hematopoietic_stem | 1.47667540 |
| 65 | MP0001845_abnormal_inflammatory_respons | 1.46553584 |
| 66 | MP0000343_altered_response_to | 1.44765609 |
| 67 | MP0008007_abnormal_cellular_replicative | 1.43723171 |
| 68 | MP0000703_abnormal_thymus_morphology | 1.39831177 |
| 69 | MP0002019_abnormal_tumor_incidence | 1.38078750 |
| 70 | MP0009840_abnormal_foam_cell | 1.33428277 |
| 71 | MP0003880_abnormal_central_pattern | 1.32503551 |
| 72 | MP0001529_abnormal_vocalization | 1.31617774 |
| 73 | MP0004858_abnormal_nervous_system | 1.31565359 |
| 74 | MP0002006_tumorigenesis | 1.31553269 |
| 75 | MP0010094_abnormal_chromosome_stability | 1.30698150 |
| 76 | MP0005083_abnormal_biliary_tract | 1.27683293 |
| 77 | MP0003111_abnormal_nucleus_morphology | 1.25184178 |
| 78 | MP0004147_increased_porphyrin_level | 1.24973585 |
| 79 | MP0008058_abnormal_DNA_repair | 1.22834511 |
| 80 | MP0004510_myositis | 1.20476563 |
| 81 | MP0004859_abnormal_synaptic_plasticity | 1.20460999 |
| 82 | MP0006035_abnormal_mitochondrial_morpho | 1.15799308 |
| 83 | MP0003787_abnormal_imprinting | 1.14711578 |
| 84 | MP0000465_gastrointestinal_hemorrhage | 1.13233642 |
| 85 | MP0002132_abnormal_respiratory_system | 1.12134513 |
| 86 | MP0002733_abnormal_thermal_nociception | 1.11323200 |
| 87 | MP0002095_abnormal_skin_pigmentation | 1.09706935 |
| 88 | MP0000313_abnormal_cell_death | 1.09261133 |
| 89 | MP0002160_abnormal_reproductive_system | 1.08038856 |
| 90 | MP0000681_abnormal_thyroid_gland | 1.06032326 |
| 91 | MP0001348_abnormal_lacrimal_gland | 1.05845838 |
| 92 | MP0000358_abnormal_cell_content/ | 1.03208630 |
| 93 | MP0001663_abnormal_digestive_system | 1.02970842 |
| 94 | MP0005058_abnormal_lysosome_morphology | 1.02794026 |
| 95 | MP0002933_joint_inflammation | 1.01520049 |
| 96 | MP0004947_skin_inflammation | 1.01000393 |
| 97 | MP0005410_abnormal_fertilization | 1.00796267 |
| 98 | MP0006054_spinal_hemorrhage | 1.00494466 |
| 99 | MP0008872_abnormal_physiological_respon | 1.00335275 |
| 100 | MP0009764_decreased_sensitivity_to | 1.00273620 |
| 101 | MP0005319_abnormal_enzyme/_coenzyme | 0.99255128 |
| 102 | MP0010352_gastrointestinal_tract_polyps | 0.98941390 |
| 103 | MP0009046_muscle_twitch | 0.98212148 |
| 104 | MP0008932_abnormal_embryonic_tissue | 0.97978101 |
| 105 | MP0005379_endocrine/exocrine_gland_phen | 0.97968015 |
| 106 | MP0003191_abnormal_cellular_cholesterol | 0.95939236 |
| 107 | MP0005084_abnormal_gallbladder_morpholo | 0.94884436 |
| 108 | MP0003075_altered_response_to | 0.93409922 |
| 109 | MP0003828_pulmonary_edema | 0.93184739 |
| 110 | MP0002102_abnormal_ear_morphology | 0.93149535 |
| 111 | MP0005451_abnormal_body_composition | 0.92661576 |
| 112 | MP0004145_abnormal_muscle_electrophysio | 0.91175437 |
| 113 | MP0005636_abnormal_mineral_homeostasis | 0.90507918 |
| 114 | MP0002735_abnormal_chemical_nociception | 0.90425657 |
| 115 | MP0003011_delayed_dark_adaptation | 0.88499636 |
| 116 | MP0008873_increased_physiological_sensi | 0.88415842 |
| 117 | MP0004742_abnormal_vestibular_system | 0.87277527 |
| 118 | MP0000015_abnormal_ear_pigmentation | 0.86889690 |
| 119 | MP0003303_peritoneal_inflammation | 0.86535815 |
| 120 | MP0000750_abnormal_muscle_regeneration | 0.85574577 |
| 121 | MP0001542_abnormal_bone_strength | 0.85447653 |
| 122 | MP0006082_CNS_inflammation | 0.84481018 |
| 123 | MP0001970_abnormal_pain_threshold | 0.83907425 |
| 124 | MP0005389_reproductive_system_phenotype | 0.83244206 |
| 125 | MP0001764_abnormal_homeostasis | 0.82151917 |
| 126 | MP0005670_abnormal_white_adipose | 0.81849879 |
| 127 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.81445411 |
| 128 | MP0000749_muscle_degeneration | 0.81149417 |
| 129 | MP0001533_abnormal_skeleton_physiology | 0.80664105 |
| 130 | MP0002638_abnormal_pupillary_reflex | 0.80614751 |
| 131 | MP0000372_irregular_coat_pigmentation | 0.79744731 |
| 132 | MP0003121_genomic_imprinting | 0.79495763 |
| 133 | MP0003221_abnormal_cardiomyocyte_apopto | 0.79314474 |
| 134 | MP0009763_increased_sensitivity_to | 0.79216890 |
| 135 | MP0001881_abnormal_mammary_gland | 0.79213830 |
| 136 | MP0009745_abnormal_behavioral_response | 0.78658929 |
| 137 | MP0000598_abnormal_liver_morphology | 0.78180741 |
| 138 | MP0009765_abnormal_xenobiotic_induced | 0.77554161 |
| 139 | MP0005330_cardiomyopathy | 0.77485395 |
| 140 | MP0009643_abnormal_urine_homeostasis | 0.77125345 |
| 141 | MP0000477_abnormal_intestine_morphology | 0.77062264 |
| 142 | MP0005220_abnormal_exocrine_pancreas | 0.74697814 |
| 143 | MP0001666_abnormal_nutrient_absorption | 0.73720383 |
| 144 | MP0001986_abnormal_taste_sensitivity | 0.72505009 |
| 145 | MP0003786_premature_aging | 0.71592309 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.35211263 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 5.25529190 |
| 3 | Aplastic anemia (HP:0001915) | 4.49291113 |
| 4 | Reticulocytopenia (HP:0001896) | 4.36138687 |
| 5 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.09688312 |
| 6 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.09688312 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.05068791 |
| 8 | Reduced antithrombin III activity (HP:0001976) | 4.00933931 |
| 9 | Thrombocytosis (HP:0001894) | 3.93501890 |
| 10 | Type I transferrin isoform profile (HP:0003642) | 3.92910373 |
| 11 | Hepatocellular necrosis (HP:0001404) | 3.87139463 |
| 12 | Hepatic necrosis (HP:0002605) | 3.78947277 |
| 13 | IgM deficiency (HP:0002850) | 3.58480253 |
| 14 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.45535541 |
| 15 | Increased intramyocellular lipid droplets (HP:0012240) | 3.38790130 |
| 16 | Macrocytic anemia (HP:0001972) | 3.38460412 |
| 17 | Mitochondrial inheritance (HP:0001427) | 3.37817571 |
| 18 | Pallor (HP:0000980) | 3.37018824 |
| 19 | Petechiae (HP:0000967) | 3.35952364 |
| 20 | Abnormal protein glycosylation (HP:0012346) | 3.20752203 |
| 21 | Abnormal glycosylation (HP:0012345) | 3.20752203 |
| 22 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.20752203 |
| 23 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.20752203 |
| 24 | Failure to thrive in infancy (HP:0001531) | 3.14321215 |
| 25 | Increased muscle lipid content (HP:0009058) | 3.14015952 |
| 26 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.12973312 |
| 27 | Acute necrotizing encephalopathy (HP:0006965) | 3.07632539 |
| 28 | Increased hepatocellular lipid droplets (HP:0006565) | 3.05032794 |
| 29 | Retinal dysplasia (HP:0007973) | 3.04190336 |
| 30 | Increased CSF lactate (HP:0002490) | 3.03548239 |
| 31 | Progressive muscle weakness (HP:0003323) | 3.03456022 |
| 32 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.02830208 |
| 33 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.97030949 |
| 34 | Progressive microcephaly (HP:0000253) | 2.93300126 |
| 35 | Lipid accumulation in hepatocytes (HP:0006561) | 2.87237130 |
| 36 | Increased serum lactate (HP:0002151) | 2.81424007 |
| 37 | Exertional dyspnea (HP:0002875) | 2.81258273 |
| 38 | Abnormality of T cell physiology (HP:0011840) | 2.81230276 |
| 39 | Microretrognathia (HP:0000308) | 2.78471263 |
| 40 | Obstructive lung disease (HP:0006536) | 2.73898301 |
| 41 | Chronic obstructive pulmonary disease (HP:0006510) | 2.73898301 |
| 42 | Chronic otitis media (HP:0000389) | 2.73487550 |
| 43 | Recurrent bronchitis (HP:0002837) | 2.70706607 |
| 44 | Lactic acidosis (HP:0003128) | 2.68517821 |
| 45 | Myositis (HP:0100614) | 2.68388434 |
| 46 | Acute encephalopathy (HP:0006846) | 2.64404708 |
| 47 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.64120289 |
| 48 | Abnormality of the prostate (HP:0008775) | 2.56766837 |
| 49 | 3-Methylglutaconic aciduria (HP:0003535) | 2.52586545 |
| 50 | Oral leukoplakia (HP:0002745) | 2.52029579 |
| 51 | Cerebral palsy (HP:0100021) | 2.49950483 |
| 52 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.49158401 |
| 53 | Multiple enchondromatosis (HP:0005701) | 2.48855111 |
| 54 | Exercise intolerance (HP:0003546) | 2.47964125 |
| 55 | Renal Fanconi syndrome (HP:0001994) | 2.44668273 |
| 56 | Ragged-red muscle fibers (HP:0003200) | 2.40506216 |
| 57 | Vacuolated lymphocytes (HP:0001922) | 2.39014880 |
| 58 | Agammaglobulinemia (HP:0004432) | 2.38325027 |
| 59 | Type II lissencephaly (HP:0007260) | 2.38164971 |
| 60 | Recurrent abscess formation (HP:0002722) | 2.38072260 |
| 61 | Pancytopenia (HP:0001876) | 2.34791018 |
| 62 | Visual hallucinations (HP:0002367) | 2.32430107 |
| 63 | Increased IgM level (HP:0003496) | 2.26479423 |
| 64 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.25503365 |
| 65 | Myokymia (HP:0002411) | 2.22657876 |
| 66 | Abnormality of macrophages (HP:0004311) | 2.21267310 |
| 67 | Prolonged bleeding time (HP:0003010) | 2.21053707 |
| 68 | Progressive macrocephaly (HP:0004481) | 2.19592305 |
| 69 | IgG deficiency (HP:0004315) | 2.19483821 |
| 70 | Optic disc pallor (HP:0000543) | 2.18190637 |
| 71 | Hyperglycinemia (HP:0002154) | 2.16839195 |
| 72 | Abnormality of the nasal mucosa (HP:0000433) | 2.16629135 |
| 73 | Abnormality of T cells (HP:0002843) | 2.16247629 |
| 74 | Respiratory failure (HP:0002878) | 2.15712960 |
| 75 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.15258443 |
| 76 | Increased serum ferritin (HP:0003281) | 2.15012334 |
| 77 | Microcytic anemia (HP:0001935) | 2.13383448 |
| 78 | Poor head control (HP:0002421) | 2.13065219 |
| 79 | Generalized aminoaciduria (HP:0002909) | 2.12101005 |
| 80 | Eczematoid dermatitis (HP:0000976) | 2.11585869 |
| 81 | Dicarboxylic aciduria (HP:0003215) | 2.10227995 |
| 82 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.10227995 |
| 83 | Cerebral hypomyelination (HP:0006808) | 2.06260529 |
| 84 | Poikiloderma (HP:0001029) | 2.04165716 |
| 85 | Abnormality of renal resorption (HP:0011038) | 2.03481657 |
| 86 | Gliosis (HP:0002171) | 2.03436132 |
| 87 | Lethargy (HP:0001254) | 2.03249410 |
| 88 | Respiratory difficulties (HP:0002880) | 2.03165823 |
| 89 | Prostate neoplasm (HP:0100787) | 2.02996765 |
| 90 | Nasal polyposis (HP:0100582) | 2.01922525 |
| 91 | Severe global developmental delay (HP:0011344) | 2.01237309 |
| 92 | Cerebral edema (HP:0002181) | 2.00976859 |
| 93 | Abnormal platelet function (HP:0011869) | 2.00946175 |
| 94 | Impaired platelet aggregation (HP:0003540) | 2.00946175 |
| 95 | Abnormality of reticulocytes (HP:0004312) | 2.00843539 |
| 96 | Retinal atrophy (HP:0001105) | 2.00840158 |
| 97 | Abnormality of B cell number (HP:0010975) | 1.99778518 |
| 98 | B lymphocytopenia (HP:0010976) | 1.99778518 |
| 99 | Muscle fiber atrophy (HP:0100295) | 1.99461228 |
| 100 | CNS demyelination (HP:0007305) | 1.99110517 |
| 101 | Hypoplasia of the pons (HP:0012110) | 1.99075729 |
| 102 | Epistaxis (HP:0000421) | 1.99036256 |
| 103 | Recurrent bacterial skin infections (HP:0005406) | 1.99003340 |
| 104 | Panhypogammaglobulinemia (HP:0003139) | 1.98802199 |
| 105 | Interstitial pulmonary disease (HP:0006530) | 1.94663037 |
| 106 | Testicular atrophy (HP:0000029) | 1.94511626 |
| 107 | Recurrent fungal infections (HP:0002841) | 1.94256891 |
| 108 | Severe visual impairment (HP:0001141) | 1.93419641 |
| 109 | Severe combined immunodeficiency (HP:0004430) | 1.93150164 |
| 110 | Gastrointestinal stroma tumor (HP:0100723) | 1.92923160 |
| 111 | Hypertensive crisis (HP:0100735) | 1.92828053 |
| 112 | Lymphoma (HP:0002665) | 1.92666001 |
| 113 | Meningitis (HP:0001287) | 1.92040655 |
| 114 | Leukodystrophy (HP:0002415) | 1.87026326 |
| 115 | Polyphagia (HP:0002591) | 1.86998842 |
| 116 | Hypoproteinemia (HP:0003075) | 1.85486799 |
| 117 | Recurrent viral infections (HP:0004429) | 1.85305235 |
| 118 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.84796947 |
| 119 | Abnormality of alanine metabolism (HP:0010916) | 1.84796947 |
| 120 | Hyperalaninemia (HP:0003348) | 1.84796947 |
| 121 | Recurrent cutaneous fungal infections (HP:0011370) | 1.83943874 |
| 122 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.83943874 |
| 123 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.82967973 |
| 124 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.82221467 |
| 125 | Microvesicular hepatic steatosis (HP:0001414) | 1.81173792 |
| 126 | Lymphopenia (HP:0001888) | 1.80353273 |
| 127 | Nausea (HP:0002018) | 1.79988366 |
| 128 | Beaking of vertebral bodies (HP:0004568) | 1.78809595 |
| 129 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.78767790 |
| 130 | Amyotrophic lateral sclerosis (HP:0007354) | 1.77711223 |
| 131 | Emotional lability (HP:0000712) | 1.77440552 |
| 132 | Recurrent skin infections (HP:0001581) | 1.77174113 |
| 133 | Rhabdomyolysis (HP:0003201) | 1.75909096 |
| 134 | Mediastinal lymphadenopathy (HP:0100721) | 1.75856711 |
| 135 | Hepatosplenomegaly (HP:0001433) | 1.73384563 |
| 136 | Opisthotonus (HP:0002179) | 1.72962400 |
| 137 | Neutropenia (HP:0001875) | 1.72051918 |
| 138 | Abolished electroretinogram (ERG) (HP:0000550) | 1.69478829 |
| 139 | Abnormality of the pons (HP:0007361) | 1.68939447 |
| 140 | Stomatitis (HP:0010280) | 1.68542331 |
| 141 | Skin rash (HP:0000988) | 1.66750980 |
| 142 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.66722769 |
| 143 | Granulocytopenia (HP:0001913) | 1.65456606 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 4.75442634 |
| 2 | VRK2 | 3.83155161 |
| 3 | MAP4K1 | 3.00250089 |
| 4 | STK16 | 2.98676668 |
| 5 | BCKDK | 2.82281717 |
| 6 | FLT3 | 2.71710649 |
| 7 | EIF2AK3 | 2.56538899 |
| 8 | KDR | 2.50262484 |
| 9 | PIM2 | 2.48309376 |
| 10 | TESK2 | 2.44309417 |
| 11 | KIT | 2.21982160 |
| 12 | WEE1 | 2.17641921 |
| 13 | BUB1 | 2.06743593 |
| 14 | MAP4K2 | 2.00504787 |
| 15 | ERN1 | 2.00395962 |
| 16 | SCYL2 | 1.91912657 |
| 17 | TBK1 | 1.89856890 |
| 18 | MAP3K11 | 1.88830849 |
| 19 | TEC | 1.81573690 |
| 20 | CDK19 | 1.81375738 |
| 21 | EIF2AK1 | 1.76483109 |
| 22 | BLK | 1.69603494 |
| 23 | LIMK1 | 1.60155800 |
| 24 | IRAK4 | 1.58142376 |
| 25 | ZAP70 | 1.57080418 |
| 26 | PKN2 | 1.51181663 |
| 27 | MAPKAPK3 | 1.45523473 |
| 28 | MUSK | 1.43144052 |
| 29 | IRAK3 | 1.41459380 |
| 30 | BTK | 1.41325395 |
| 31 | TNIK | 1.39093296 |
| 32 | VRK1 | 1.38701625 |
| 33 | LRRK2 | 1.38190508 |
| 34 | TLK1 | 1.35755184 |
| 35 | CSNK1G3 | 1.34321575 |
| 36 | TYK2 | 1.33197402 |
| 37 | MAP3K12 | 1.31273263 |
| 38 | TAOK3 | 1.30671519 |
| 39 | ARAF | 1.30237725 |
| 40 | ACVR1B | 1.27781382 |
| 41 | MAP2K7 | 1.23308874 |
| 42 | MAP2K3 | 1.22368273 |
| 43 | RPS6KB2 | 1.20918861 |
| 44 | IKBKE | 1.19009384 |
| 45 | ZAK | 1.18330681 |
| 46 | CSF1R | 1.15735065 |
| 47 | SYK | 1.11852551 |
| 48 | CAMKK2 | 1.08753159 |
| 49 | DYRK3 | 1.08180372 |
| 50 | ADRBK2 | 1.05024829 |
| 51 | TGFBR1 | 1.04000110 |
| 52 | EEF2K | 1.03178942 |
| 53 | JAK3 | 1.02009775 |
| 54 | DYRK2 | 1.00189248 |
| 55 | MYLK | 0.99608842 |
| 56 | CSNK1G2 | 0.99346047 |
| 57 | TIE1 | 0.96878986 |
| 58 | CSNK1A1L | 0.94355282 |
| 59 | CDC7 | 0.93443915 |
| 60 | RPS6KA4 | 0.91888671 |
| 61 | ILK | 0.91020941 |
| 62 | TXK | 0.89806205 |
| 63 | GRK6 | 0.89244997 |
| 64 | TESK1 | 0.87750615 |
| 65 | MATK | 0.86618417 |
| 66 | RPS6KA5 | 0.84788133 |
| 67 | DAPK3 | 0.81980957 |
| 68 | RAF1 | 0.81939936 |
| 69 | LYN | 0.80786690 |
| 70 | NLK | 0.80702800 |
| 71 | TRIB3 | 0.78752257 |
| 72 | NEK1 | 0.78285424 |
| 73 | GRK5 | 0.76885154 |
| 74 | IKBKB | 0.74944288 |
| 75 | NEK2 | 0.73303212 |
| 76 | FES | 0.73060604 |
| 77 | CDK7 | 0.71722172 |
| 78 | ABL2 | 0.71331391 |
| 79 | CSNK1G1 | 0.70235807 |
| 80 | PRKG2 | 0.69694783 |
| 81 | NME1 | 0.69179236 |
| 82 | BRAF | 0.68752178 |
| 83 | NUAK1 | 0.68217358 |
| 84 | MAP3K10 | 0.67715425 |
| 85 | MAP3K8 | 0.66632694 |
| 86 | LCK | 0.63913842 |
| 87 | PIM1 | 0.63291546 |
| 88 | MAP2K2 | 0.62521844 |
| 89 | SMG1 | 0.61858938 |
| 90 | MAP2K6 | 0.58872947 |
| 91 | GRK1 | 0.58621041 |
| 92 | CHEK2 | 0.53430263 |
| 93 | BRSK2 | 0.52245990 |
| 94 | CAMK2G | 0.52211833 |
| 95 | CAMK2B | 0.51927904 |
| 96 | CDK14 | 0.51768948 |
| 97 | PRKCI | 0.51551708 |
| 98 | RIPK4 | 0.51058857 |
| 99 | CDK8 | 0.50823112 |
| 100 | MAP3K1 | 0.49770162 |
| 101 | RPS6KL1 | 0.48957851 |
| 102 | RPS6KC1 | 0.48957851 |
| 103 | AURKB | 0.48930291 |
| 104 | TGFBR2 | 0.48876383 |
| 105 | MAPK11 | 0.48703098 |
| 106 | PAK4 | 0.48448200 |
| 107 | GRK7 | 0.48239156 |
| 108 | RPS6KA6 | 0.46399446 |
| 109 | TNK2 | 0.45941457 |
| 110 | DYRK1B | 0.45648612 |
| 111 | DAPK1 | 0.45280767 |
| 112 | CDK11A | 0.44733733 |
| 113 | WNK4 | 0.44605642 |
| 114 | CDK4 | 0.44247926 |
| 115 | CAMK1 | 0.43604687 |
| 116 | MAPK13 | 0.42540734 |
| 117 | TAOK2 | 0.41004539 |
| 118 | PINK1 | 0.40917820 |
| 119 | AURKA | 0.40524811 |
| 120 | CDK15 | 0.40486281 |
| 121 | ATR | 0.39220606 |
| 122 | SRPK1 | 0.38059542 |
| 123 | TAOK1 | 0.37429203 |
| 124 | CDK18 | 0.37102907 |
| 125 | PLK1 | 0.35702451 |
| 126 | MARK3 | 0.35142765 |
| 127 | EIF2AK2 | 0.34779223 |
| 128 | PAK1 | 0.34545355 |
| 129 | MAPK4 | 0.34373941 |
| 130 | MAPKAPK5 | 0.34122270 |
| 131 | PRKCD | 0.33988259 |
| 132 | CSNK2A2 | 0.33580865 |
| 133 | CAMK2D | 0.32597881 |
| 134 | HCK | 0.32296433 |
| 135 | PRKCQ | 0.31684675 |
| 136 | PKN1 | 0.31659066 |
| 137 | CSNK2A1 | 0.31490238 |
| 138 | MAP3K4 | 0.30971829 |
| 139 | CCNB1 | 0.30721099 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.71649545 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 4.33037311 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.18150654 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 2.85212972 |
| 5 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.41733500 |
| 6 | Sulfur relay system_Homo sapiens_hsa04122 | 2.40360296 |
| 7 | Base excision repair_Homo sapiens_hsa03410 | 2.39749712 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 2.32066816 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.31246315 |
| 10 | RNA polymerase_Homo sapiens_hsa03020 | 2.27188458 |
| 11 | Protein export_Homo sapiens_hsa03060 | 2.17896405 |
| 12 | Homologous recombination_Homo sapiens_hsa03440 | 2.11432468 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.04031694 |
| 14 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.02894021 |
| 15 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.93298622 |
| 16 | Spliceosome_Homo sapiens_hsa03040 | 1.82306633 |
| 17 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.78519248 |
| 18 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.62174233 |
| 19 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.59490606 |
| 20 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.56530945 |
| 21 | Huntingtons disease_Homo sapiens_hsa05016 | 1.52363742 |
| 22 | Other glycan degradation_Homo sapiens_hsa00511 | 1.45112345 |
| 23 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.44154162 |
| 24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.43177254 |
| 25 | Alzheimers disease_Homo sapiens_hsa05010 | 1.40379392 |
| 26 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.35633841 |
| 27 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.35565729 |
| 28 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.35090366 |
| 29 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.34557917 |
| 30 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.34198331 |
| 31 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.24739191 |
| 32 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.21467097 |
| 33 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.13757889 |
| 34 | Purine metabolism_Homo sapiens_hsa00230 | 1.09275605 |
| 35 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.06276209 |
| 36 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.05006059 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.04747441 |
| 38 | Phototransduction_Homo sapiens_hsa04744 | 1.03842636 |
| 39 | Galactose metabolism_Homo sapiens_hsa00052 | 1.03578284 |
| 40 | Leishmaniasis_Homo sapiens_hsa05140 | 1.03372169 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.01839696 |
| 42 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.97006682 |
| 43 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.94919888 |
| 44 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.94694090 |
| 45 | RNA transport_Homo sapiens_hsa03013 | 0.94218118 |
| 46 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.93995863 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 0.93974946 |
| 48 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.93393730 |
| 49 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.90781604 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.90227814 |
| 51 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.89899494 |
| 52 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.88930756 |
| 53 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.87964677 |
| 54 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.85858196 |
| 55 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.85605408 |
| 56 | Allograft rejection_Homo sapiens_hsa05330 | 0.84227573 |
| 57 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.82189045 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.81707579 |
| 59 | Legionellosis_Homo sapiens_hsa05134 | 0.80840671 |
| 60 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.80119671 |
| 61 | Measles_Homo sapiens_hsa05162 | 0.79888579 |
| 62 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.79419026 |
| 63 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.78417492 |
| 64 | RNA degradation_Homo sapiens_hsa03018 | 0.76456456 |
| 65 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.73141766 |
| 66 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.72065833 |
| 67 | Thyroid cancer_Homo sapiens_hsa05216 | 0.70833734 |
| 68 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.69716330 |
| 69 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.69534907 |
| 70 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.69299529 |
| 71 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.68935877 |
| 72 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.68200741 |
| 73 | Cell cycle_Homo sapiens_hsa04110 | 0.67519194 |
| 74 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.67420419 |
| 75 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.65825440 |
| 76 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.65428084 |
| 77 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.63737473 |
| 78 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.62852002 |
| 79 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.62814956 |
| 80 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.62784705 |
| 81 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62326960 |
| 82 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.61606098 |
| 83 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.61054243 |
| 84 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.60445005 |
| 85 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.59114859 |
| 86 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.58302073 |
| 87 | Metabolic pathways_Homo sapiens_hsa01100 | 0.57616192 |
| 88 | Apoptosis_Homo sapiens_hsa04210 | 0.57327792 |
| 89 | Pertussis_Homo sapiens_hsa05133 | 0.55301770 |
| 90 | Salmonella infection_Homo sapiens_hsa05132 | 0.54916021 |
| 91 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.53356544 |
| 92 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.52776245 |
| 93 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.52225976 |
| 94 | Viral myocarditis_Homo sapiens_hsa05416 | 0.52143850 |
| 95 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.52026710 |
| 96 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.51796123 |
| 97 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.51429765 |
| 98 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.51243064 |
| 99 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.50479662 |
| 100 | Olfactory transduction_Homo sapiens_hsa04740 | 0.50190257 |
| 101 | Shigellosis_Homo sapiens_hsa05131 | 0.49379122 |
| 102 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.48628023 |
| 103 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.46234753 |
| 104 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.43160190 |
| 105 | Influenza A_Homo sapiens_hsa05164 | 0.43100774 |
| 106 | Basal transcription factors_Homo sapiens_hsa03022 | 0.40424327 |
| 107 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40388359 |
| 108 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39732403 |
| 109 | Malaria_Homo sapiens_hsa05144 | 0.38999510 |
| 110 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.38869992 |
| 111 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.36782445 |
| 112 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.36225293 |
| 113 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.36092066 |
| 114 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.34305788 |
| 115 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.33985873 |
| 116 | Asthma_Homo sapiens_hsa05310 | 0.32750144 |
| 117 | Tuberculosis_Homo sapiens_hsa05152 | 0.31836601 |
| 118 | Hepatitis B_Homo sapiens_hsa05161 | 0.31833849 |
| 119 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.29844830 |
| 120 | Peroxisome_Homo sapiens_hsa04146 | 0.29782665 |
| 121 | Lysosome_Homo sapiens_hsa04142 | 0.29540025 |
| 122 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.28914045 |
| 123 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.28763592 |
| 124 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.26759147 |
| 125 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.26499401 |
| 126 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.26043675 |
| 127 | Alcoholism_Homo sapiens_hsa05034 | 0.26039771 |
| 128 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.25521875 |
| 129 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.25215212 |
| 130 | Phagosome_Homo sapiens_hsa04145 | 0.24927716 |
| 131 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.24779876 |
| 132 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.24014319 |
| 133 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.23894909 |
| 134 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.23671251 |
| 135 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.23642357 |
| 136 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.20979853 |

